Delivery Order SPE2DB22D3501-SPE2DB24FWK90
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract, SPE2DX15D3020|SPE2DX24FXMWX, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Copaxone 40 mg/ml syringes. The contract has a ceiling value of $3,126.39 and a performance period through March 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COPAXONE 40 MG/ML SYRINGE medication. The $6,333.12 contract has a completion date of January 31, 2024 and does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is a prime contractor that supplies pharmaceuticals, medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE medicine. The award has a potential value of $4,842.48 and a completion date of February 16, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00, which serves as the primary contract vehicle for...
This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company has been...
This federal contract award, with a ceiling value of $12,053.49, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the supply of COPAXONE 40 MG/ML SYRINGES, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,583.28 firm fixed price delivery order contract (SPE2DX15D2109|SPE2DX24F0L9D) by the Defense Logistics Agency (DLA) Troop Support Medical to provide Copaxone 40 mg/ml syringes. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The $11,777.66 delivery order contract is a Firm Fixed Price arrangement with a completion date of May 21, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical covering a wide range of medical commodities including...
This federal contract award, with the ID SPE2DB22D1002|SPE2DB25FKXZ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,652.47 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication, with a completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $1,583.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML syringes. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...